UT Southwestern Medical Center
UT Southwestern Medical Center
The Center for Translational Medicine (CTM) at UT Southwestern is a collaboration among 7 academic institutions, 5 health care systems, 6 teaching hospitals, and the North Texas community. Our mission is to improve health in local and global communities through innovation and education. Over the past 11 years, the CTM catalyzed disruptive innovation and transformed the culture and landscape of our institution and its partners. We have supported more than 1,400 investigators, trained >1,000 members of the translational workforce, and we co-led the formation of the Accrual to Clinical Trials CTSA network. We have established new translational technologies, new methods, and processes critical to the translational process at every level and engaged our local communities early on in the design and conduct of clinical research.
UT Southwestern Medical CenterThe Integrating CTS into the CTSA Virtual Visiting Scholar Program Working Group is pleased to announce a Grand Rounds Lecture. Please join us on Friday, May 5, 2023 at 12:00pm CT. Matthew Harer, Associate Professor, Division of Neonatology and Newborn Nursery, University of Wisconsin School of Medicine and Public Health, will present: Improving childhood kidney outcomes in former premature
January 23, 2023How often is Expanded Access used, and how often is support for it available? This is what the TEAMSS (Transforming Expanded Access to Maximize Support and Study) collaborative set out to determine through a survey of academic medical centers through the CTSA (Clinical and Translational Science Awards) network. Forty-seven sites responded, and the findings have now been published in the Journal of- UT Southwestern Medical CenterAuthors Farra Kahalnik1, MPH, MSSW, Adam Loewen1, Nora Gimpel1,2, MD, Tracy L. Greer1,3, PhD, MSCS 1UT Southwestern, CTSA Program 2UT Southwestern, Department of Family and Community Medicine 3UT Arlington, Department of Psychology Background UT Southwestern has a strong foundation of utilizing community engagement strategies to integrate research evidence and stakeholder priorities to improve
Focal and Segmental Glomerulosclerosis, Minimal Change Disease, and Membranous Nephropathy, presenting as Nephrotic Syndrome (NS), are a group of rare renal diseases that may cause serious complications and end-stage kidney disease, generating significant individual, societal and economic burdens. The Nephrotic Syndrome Study Network (NEPTUNE) brings together physician scientists at 26 sites in
Autism spectrum disorder (ASD) affects 1 in 59 children in the United States and is a major public health concern and challenge. The Developmental Synaptopathies Consortium (DSC) aims to explore the underlying causes of autism by focusing on three rare genetic disorders related to ASD, including Tuberous Sclerosis Complex (TSC), PTEN Hamartoma Tumor Syndrome (PHTS) and Phelan-McDermid Syndrome
The Greater Plains Collaborative (GPC) is a network of 12 leading medical centers in eight states committed to a shared vision of improving healthcare delivery through ongoing learning, adoption of evidence-based practices, and active research dissemination. GPC builds on strong research programs at individual sites, existing community engagement and informatics infrastructures and data warehouses
With its Lowering the Barriers program, the Texas CTSA Consortium is facilitating collaboration among the Texas CTSAs and other interested biomedical research institutions by an IRB reciprocity agreement and sharing of resources, expertise, and patient populations. The Texas CTSAs' BERD, bioinformatics, ethics, and PCIR components are meeting regularly to exchange best practices and tackle joint